ArticleBMJ open ophthalmology2022
Interexaminer reproducibility for subjective refractions for an ametropic participant.
Article in BMJ open ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 8 citations in OpenAlex.
- Feasibility, agreement, and time savings of PHANTOM open-field binocular integrated refraction versus conventional clinical refraction in healthy young adults.BMC ophthalmology · 2026Article
- Comparison of refractive parameters provided by a new open field aberrometer and the subjective refraction.BMC ophthalmology · 2026Observational
- Comparing Close-Field and Open-Field Autorefractometry and Subjective Refraction.Journal of clinical medicine · 2025Article
- Ametropia detection using a novel, compact wavefront autorefractor.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2024Article
- Comprehensive Primary Eye Care: A Comparison Between an In-Person Eye Exam and a Tele-Eye Care Exam.Clinical optometry · 2024Article
- Assessment of an algorithm-based combination device for objective and subjective refraction: accuracy and efficiency across examiner experience levels.Journal of optometryArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate interexaminer reproducibility of non-cycloplegic subjective refractions. Subjective refractions are frequently determined, and it is important to know whether differences in refractive state over time constitute meaningful, non-random change. METHODS AND ANALYSIS: Fifty registered and experienced (≥5 years) optometrists from a single geographic region performed non-cycloplegic subjective refractions for a participant with moderate left eye(OS) to severe right eye (OD) ametropia. Subjective refractions were transformed to power matrices for analysis with stereopairs, distribution ellipsoids and polar profiles of variance of dioptric power. Absolute 95% limits of reproducibility ([Formula: see text](SD)) for excesses of subjective refractions for the right and left eyes separately from mean subjective refractions were determined.
resultsMean subjective refractions were -7.68-4.50×10 and -4.59-1.85×178 for the right and left eyes, respectively. The 95% absolute reproducibility limits for the stigmatic coefficients (spherical equivalents) were ≤1.71 D and ≤0.75 D for the right and left eyes, but corresponding limits for astigmatic coefficients were smaller (≤0.69 D).
conclusionRemoval of possible outliers for OD and OS, respectively, reduces the absolute 95% reproducibility limits for the stigmatic and astigmatic coefficients to ≤0.97 D and ≤0.49 D, thus improving interexaminer reproducibility. However, these results suggest caution with analysis of refractive data where subjective rather than objective methods are applied for longitudinal and epidemiological studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.